Evaluation of the efficacy of methotrexate and cyclosporine therapies on psoriatic nails: A one-blind, randomized study

Journal of the European Academy of Dermatology and Venereology

Volumn 25, Issue 9, 2011, Pages 1080-1084

  Gumusel M ^a   Ozdemir M ^a   Mevlitoglu A ^a   Bodur, S ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

cyclosporine; methotrexate; NAPSI; psoriatic nail

Indexed keywords

AMINOTRANSFERASE; CREATININE; CYCLOSPORIN; FOLIC ACID; LIPID; METHOTREXATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HIRSUTISM; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; MALE; NAIL BED; NAIL DISEASE; NAIL PSORIASIS; NAUSEA; OUTCOME ASSESSMENT; PAIN; PHYSICIAN; PRIORITY JOURNAL; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; SINGLE BLIND PROCEDURE; TELOGEN EFFLUVIUM;

CYCLOSPORINE; HUMANS; METHOTREXATE; NAIL DISEASES; PSORIASIS; SINGLE-BLIND METHOD;

EID: 80051684474     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2010.03927.x     Document Type: Article

References (20)

1. Jiaravuthisan MM, Sasseville D, Vender RB, Murphy F, Muhn CY,. Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. J Am Acad Dermatol 2007; 57: 1-27. (Pubitemid 46899261)
2. Berker D,. Management of nail psoriasis. Clin Exp Dermatol 2000; 25: 357-362.
3. Soy M, Karaca N, Umit EU, Bes C, Piskin S,. Joint and nail involvement in Turkish patients with psoriatic arthritis. Rheumatol Int 2008; 29: 223-225.
4. Rigopoulus D, Gregoriou S, Stratigos A, et al. Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study. Br J Dermatol 2008; 159: 453-456. (Pubitemid 352009870)
5. Cassel S, Kavanaugh A,. Therapies for psoriatic nail disease: a systematic review. J Rheumatol 2006; 31: 1452-1456. (Pubitemid 44025169)
6. Tosti A, Ricotti C, Romanelli P, Cameli N, Piraccini BM,. Evaluation of the efficacy of acitretin therapy for nail psoriasis. Arch Dermatol 2009; 145: 269-271.
7. Feliciani C, Zampetti A, Forleo P, et al. Nail psoriasis: combined therapy with systemic cyclosporin and topical calcipotriol. J Cutan Med Surg 2004; 8: 122-125. (Pubitemid 38781366)
8. Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol 2009; 61: 451-485.
9. Rich P, Scher RK,. Nail psoriasis severity index: a useful tool for evaluation of nail psoriasis. J Am Dermatol 2003; 49: 206-212. (Pubitemid 36951265)
10. Heyden VMR, Spuls PI, Opmeer BC, et al. Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis. N Engl J Med 2003; 349: 658-665. (Pubitemid 36975998)
11. Gupta AK, Cooper EA,. Psoriatic nail disease: quality of life and treatment. J Cutan Med Surg 2009; 13 (Suppl 2): 102-106.
12. Noiles K, Vender R,. Nail psoriasis and biologics. J Cutan Med Surg 2009; 13: 1-5.
13. Berker D,. Management of psoriatic nail disease. Semin Cutan Med Surg 2009; 28: 39-43.
14. Syuto T, Abe M, Ishibuchi H, Ishikawa O,. Successful treatment of psoriatic nails with low -dose cyclosporine administration. Eur J Dermatol 2007; 17: 248-249. (Pubitemid 46847795)
15. Mahrle G, Schulze HJ, Farber L, Weidinger G, Steigleder GK,. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement. J Am Acad Dermatol 1995; 32: 78-88.
16. Tosti A, Piraccini BM,. Treatment of common nail disorders. Dermatol Clin 2000; 18: 339-348. (Pubitemid 30220650)
17. Cher RK, Stiller M, Zhu YI,. Tazoratene 0. 1% gel in the treatment of fingernail psoriasis: a double-blind, randomized, vehicle-controlled study. Cutis 2001; 68: 355-358. (Pubitemid 33756739)
18. Lawry M,. Biological therapy and nail psöriasis. Dermatol Ther 2007; 20: 60-67.
19. Bianchi L, Bergamin A, Felice C, Capriotti E, Chimenti S,. Remission and time of resolution of nail psoriasis during infliximab therapy. J Am Acad Dermatol 2005; 52: 736-737. (Pubitemid 40585474)
20. Rich P, Griffith CEM, Reich K, et al. Baseline nails disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year. J Am Acad Dermatol 2008; 58: 224-231.